Cambridge Spinout Broken String Biosciences Raises $15M To Make Cell And Gene Therapies Safer And Affordable
Sep 18, 2023•almost 2 years ago
Amount Raised
$15 Million
Investors
Arnaud AutretYoann BonnamourDieter Von Holtzbrinck VenturesTencentHeran PartnersMérieux Equity PartnersIllumina Ventures
Description
Now, Broken String Biosciences has picked up $15 million in Series A funding. The investment round was co-led by Illumina Ventures, which recently backed Lightcast Discovery and Mérieux Equity Partners, with contributions from HERAN Partners, and existing investors Tencent and Dieter von Holtzbrinck Ventures (DvH Ventures). As part of the round, Yoann Bonnamour, Mérieux Equity Partners, and Arnaud Autret, Illumina Ventures, join the company’s Board of Directors.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech